1. Home
  2. CERO vs KXIN Comparison

CERO vs KXIN Comparison

Compare CERO & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • KXIN
  • Stock Information
  • Founded
  • CERO 2017
  • KXIN 2015
  • Country
  • CERO United States
  • KXIN China
  • Employees
  • CERO N/A
  • KXIN N/A
  • Industry
  • CERO
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • CERO
  • KXIN Consumer Discretionary
  • Exchange
  • CERO Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • CERO 3.1M
  • KXIN 2.8M
  • IPO Year
  • CERO N/A
  • KXIN N/A
  • Fundamental
  • Price
  • CERO $0.73
  • KXIN $0.92
  • Analyst Decision
  • CERO
  • KXIN
  • Analyst Count
  • CERO 0
  • KXIN 0
  • Target Price
  • CERO N/A
  • KXIN N/A
  • AVG Volume (30 Days)
  • CERO 1.0M
  • KXIN 92.7K
  • Earning Date
  • CERO 05-16-2025
  • KXIN 01-01-0001
  • Dividend Yield
  • CERO N/A
  • KXIN N/A
  • EPS Growth
  • CERO N/A
  • KXIN N/A
  • EPS
  • CERO N/A
  • KXIN N/A
  • Revenue
  • CERO N/A
  • KXIN N/A
  • Revenue This Year
  • CERO N/A
  • KXIN N/A
  • Revenue Next Year
  • CERO N/A
  • KXIN N/A
  • P/E Ratio
  • CERO N/A
  • KXIN N/A
  • Revenue Growth
  • CERO N/A
  • KXIN N/A
  • 52 Week Low
  • CERO $0.65
  • KXIN $0.90
  • 52 Week High
  • CERO $223.00
  • KXIN $29.52
  • Technical
  • Relative Strength Index (RSI)
  • CERO 26.02
  • KXIN 25.41
  • Support Level
  • CERO $0.65
  • KXIN $0.90
  • Resistance Level
  • CERO $0.80
  • KXIN $1.04
  • Average True Range (ATR)
  • CERO 0.10
  • KXIN 0.06
  • MACD
  • CERO 0.04
  • KXIN 0.01
  • Stochastic Oscillator
  • CERO 20.79
  • KXIN 8.39

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: